Okomera

Proud to join the Benchling for startups program - to connect our Okomera wetlab experiments to the cloud ☁️ Exciting times to connect all our wetlab organoid data to our cloud platform hosted by Amazon Web Services (AWS) and power our AI pipeline 💥 Thanks Camille Gollety and Pawan Patel for inviting us - we are excited about the future !

We're selected in the oncoentrepreneur of Paris Saclay Cancer Cluster (PSCC)) ! A tailored program to boost our collaboration with pharma and top clinical centers in France and Europe - can't wait to get started ! PSCC is built around the leading cancer center Gustave Roussy but much more thanks Nouzha Mohellibi catherine laporte Thierry Jean !

Glad to welcome Mourad FERHAT, PhD Idil Arioz Mesure Turkes from Acro Biosystem in our Paris office ! Exciting to learn more about their Mogengel extracellular matrix and their organoid solutions !

Great example of Cell therapy platform financed by Paris Saclay Cancer Cluster - CellAction at Curie institute presented by Marion Alcantara 🔬 Focus: CAR-T therapies—modifying immune cells (T lymphocytes) to target and destroy cancer cells. 📈 Goal: Expand these therapies from blood cancers to solid tumors, revolutionizing immuno-oncology 📅 Clinical trials for solid tumors planned for 2026!

Can lymphoid organs-on-chip be used to evaluate the effectiveness of booster vaccines? 🧫Pasteur Institute researchers led by Lisa Chakrabarti have developed a "lymphoid organ-on-chip" technology that simulates the human immune system's response to booster vaccines. This system mimics the interaction of human immune cells—specifically B and T cells—in response to vaccine antigens. These cells can cluster and activate within the chip, producing antibodies that neutralize SARS-CoV-2. 🦠The system's capability to handle various immune cell types and its response to mRNA COVID vaccines has demonstrated variability in immune responses based on different donors' blood. This variability reflects the diverse immunological backgrounds found in human populations, making the organ-on-chip a valuable tool for preclinical vaccine testing, especially in adapting to the dynamic nature of the SARS-CoV-2 pandemic. Credit : https://lnkd.in/gd6dUgAe Below : After exposing the lymphoid organ-on-chip to viral proteins, activated T cells (in purple) and B cells (in cyan) cluster together to promote antibody production, just as they do in real lymphoid organs.

Glad to be at Institut Curie next Tuesday Nov 19th for Innovation day in Biotherapies and Bioproduction! Looking forward to meet vibrant biotech and research ecosystem. Don't hesitate to ping me!

Pitch rehearsal for the Demo Night of Pfizer Wilco accelerator program - PHHF! Join us!

📅 Join us today for the Demo Day of Pfizer Healthcare Hub France - a high-energy accelerator event by Pfizer and WILCO 🙏 A big shout-out to our mentors on this journey to fine-tune our technology features for the big pharma needs - Sylvie Troy Julien Laurencin Eric Garnier Amele Seghaier Inès Pouradier Duteil Agenda Highlights : 🔹A look into tomorrow's health challenges with Franck Mouthon from INSERM 🔹Startup and Alumni pitch 🔹Great networking night 👉 Sign up here : https://lnkd.in/edB2kzDi

📅 Join us this Thursday Nov 14th for the Demo Day of Pfizer Healthcare Hub France - a high-energy accelerator event by Pfizer and WILCO 🙏 A big shout-out to our mentors on this journey to fine-tune our technology features for the big pharma needs - Sylvie Troy Julien Laurencin Eric Garnier Amele Seghaier Inès Pouradier Duteil Agenda Highlights : 🔹A look into tomorrow's health challenges with Franck Mouthon from INSERM 🔹Startup and Alumni pitch 🔹Great networking night 👉 Sign up here : https://lnkd.in/edB2kzDi

Had to share this impressive new entrance building of the Karolinska Institutet - I was blown away during my evening walk in the Solna campus with Hans Grönlund. Enjoy the view! 🇸🇪